25 May 2013
Keywords: isis, pfizer, collaborate, eye, disease, antisense, treatments
Article | 30 May 2005
The USA's Isis Pharmaceuticals has struck a deal with the world's largest drugmaker, Pfizer, to develop antisense treatments for eye
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 May 2005
24 May 2013
© 2013 thepharmaletter.com